N. Vuilleumier

Type de document

Articles (14)

Co-auteur

Date

Source

Mot-clé

Human beings (7) risque (6) association (6) Social groups (6) Risk (6) Immunoglobulin G (6) Patients (5) Impact (5) Confidence (5) Autoantibodies (5) Patients (5) mortalité (4) danger (4) âge (4) adulte (4) Mortality (4) Population (4) Mortality (4) Older people (4) Age (4) Age (4) Population (4) cohorte (4) adulte (4) puits (3) temps (durée) (3) gène (3) effet (3) maladie cardiovasculaire (3) biomarqueur (3)

Documents écrit par N. Vuilleumier (14) | parle de N. Vuilleumier (0)

Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients.
H. Wozniak et al. (26 juil. 2023)
Straightforward quantification of endogenous steroids with liquid chromatography-tandem mass spectrometry: Comparing calibration approaches.
G. Visconti et al. (15 juil. 2023)
Changes of lipoprotein(a) levels with endogenous steroid hormones.
E. Tessitore et al.
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
S. Stringhini et al. (8 juin 2021)
Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatment.
M.C. Brulhart-Meynet et al.
Gene regulation contributes to explain the impact of early life socioeconomic disadvantage on adult inflammatory levels in two cohort studies.
C. Carmeli et al. (4 févr. 2021)
Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.
N. Vuilleumier et al. (2020)
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.
N. Vuilleumier et al. (9 juil. 2019)
Automated Incubation and Digital Image Analysis of Chromogenic Media Using Copan WASPLab Enables Rapid Detection of Vancomycin-Resistant Enterococcus.
A. Cherkaoui et al. (2019)
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
P. Antiochos et al.
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms.
P. Antiochos et al. (2017)
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
P. Antiochos et al. (27 sept. 2016)
Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism.
N. Vuilleumier et al. (2016)
Improving Reconstituted HDL Composition for Efficient Post-Ischemic Reduction of Ischemia Reperfusion Injury.
M.C. Brulhart-Meynet et al. (2015)